Lmr Partners LLP Astrazeneca PLC Transaction History
Lmr Partners LLP
- $10.9 Billion
- Q3 2024
A detailed history of Lmr Partners LLP transactions in Astrazeneca PLC stock. As of the latest transaction made, Lmr Partners LLP holds 50,000 shares of AZN stock, worth $3.28 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
50,000
Previous 25,886
93.15%
Holding current value
$3.28 Million
Previous $2.02 Million
93.06%
% of portfolio
0.04%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.13 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.76 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.44 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.42 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.27 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...